Skip to main content

Want a detailed portfolio tracker?

MeiraGTx (MGTX) P/E (2018 - 2026)

MeiraGTx (MGTX) P/E from Jul 2, 2018 to Jun 3, 2026. The TTM MeiraGTx (MGTX) P/E is -6.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of MeiraGTx (MGTX)

YearP/EChange
2026-6.29+12.95%
2025-5.57+90.10%
2024-2.93+1.42%
2023-2.89+11.23%
2022-2.60-80.37%
2021-13.23+31.97%
2020-10.02-19.96%
2019-12.52+216.86%
2018-3.95N/A

Comparison MeiraGTx (MGTX) P/E with competitors

MeiraGTx (MGTX) P/E is -6.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.10-101.62%
ENLVEnlivex Therapeutics Ltd0.15-102.39%
FGENFibroGen Inc0.24-103.81%
TRAWTraws Pharma Inc0.47-107.51%
FBIOFortress Biotech Inc0.71-111.22%
CHRSCoherus Biosciences Inc0.98-115.55%
ORMPOramed Pharmaceuticals Inc1.47-123.42%
AGENAgenus Inc2.05-132.56%
VIVSVivoSim Labs Inc2.54-140.30%
INVAInnoviva Inc3.19-150.67%
CRMDCorMedix Inc3.65-157.94%
ABEOAbeona Therapeutics Inc4.20-166.83%
VXRTVaxart Inc4.26-167.73%
CVACCureVac N.V.4.45-170.65%
SRPTSarepta Therapeutics Inc4.62-173.49%
GLPGGalapagos NV4.86-177.22%
RIGLRigel Pharmaceuticals4.92-178.19%
ZVRAZevra Therapeutics Inc4.97-179.05%
ABUSArbutus Biopharma Corp5.69-190.49%
CGENCompugen Ltd7.38-217.35%
AUPHAurinia Pharmaceuticals Inc9.25-247.03%
ACADAcadia Pharmaceuticals Inc9.59-252.38%
OMEROmeros Corporation9.88-257.08%
PLXProtalix BioTherapeutics Inc9.91-257.49%
SPROSpero Therapeutics Inc10.73-270.61%
ADMAAdma Biologics Inc11.33-280.08%
SVASinovac Biotech Ltd11.44-281.75%
TBPHTheravance Biopharma Inc11.78-287.17%
HRMYHarmony Biosciences Holdings Inc12.18-293.58%
TGTXTG Therapeutics Inc13.18-309.46%
INCYIncyte Corp13.38-312.68%
SABSSAB Biotherapeutics Inc14.06-323.42%
XOMAXOMA Corp14.95-337.53%
REGNRegeneron Pharmaceuticals Inc14.98-338.08%
PBYIPuma Biotechnology Inc15.05-339.20%
EXELExelixis Inc15.79-351.03%
NAGENiagen Bioscience Inc16.35-359.93%
CPRXCatalyst Pharmaceuticals Inc17.34-375.66%
MDXGMimedx Group Inc17.38-376.15%
ARGXArgen X SE23.07-466.68%
HALOHalozyme Therapeutics Inc23.20-468.73%
XOMAOXOMA Corp25.34-502.81%
VRTXVertex Pharmaceuticals Inc25.66-507.75%
XOMAPXOMA Corp25.67-507.98%
CTMXCytomX Therapeutics Inc25.70-508.42%
ASNDAscendis Pharma A/S26.35-518.85%
RPRXRoyalty Pharma plc - Class A27.50-536.99%
SLNOSoleno Therapeutics Inc29.02-561.14%
LGNDLigand Pharmaceuticals Inc - Class B30.19-579.76%
BMRNBiomarin Pharmaceutical Inc37.51-696.11%
APLSApellis Pharmaceuticals Inc39.02-720.17%
KRYSKrystal Biotech Inc39.70-730.92%
GMABGenmab40.20-738.96%
ONCBeiGene Ltd67.03-1165.27%
TECHBio-Techne Corp68.59-1190.19%
VCELVericel Corp80.63-1381.45%
PHARPharming Group N.V.87.74-1494.47%
ALNYAlnylam Pharmaceuticals Inc124.93-2085.59%
TLXTelix Pharmaceuticals Ltd139.89-2323.30%
CORTCorcept Therapeutics Inc158.39-2617.30%